IMV Phase 2 clinical results with Merck Keytruda in DLBCL - ICML Update
Speakers
Fred Ors, President and CEO
Pierre Labbe, Vice-President and CFO
Gabriela Rosu, MD, Chief Medical Officer
Stephan Fiset, Vice-President Clinical Research
Marianne Stanford, Ph.D., Vice-President, Research and Development